Fortify
Fortify, licence 80058440: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Crosscor Inc.
- NPN or DIN-HM
- 80058440
- Status
- Active licence
- Licence date
- 24 February 2015
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine E | 136.0 mg AT | Not calculated |
| Vitamine E | 200.0 UI | Not calculated |
| Potassium | 100.0 milligramme | Not calculated |
| Bêta-carotène | 9.0 milligramme | Not calculated |
| Bêta-carotène | 15000.0 UI | Not calculated |
| Thiamine | 100.0 milligramme | Not calculated |
| Riboflavine | 50.0 milligramme | Not calculated |
| 3-Pyridinecarboxamide | 100.0 milligramme | Not calculated |
| Vitamine B6 | 100.0 milligramme | Not calculated |
| Folate | 400.0 microgrammes | Not calculated |
| Vitamine B12 | 250.0 microgrammes | Not calculated |
| Biotine | 300.0 microgrammes | Not calculated |
| Vitamine C | 500.0 mg | Not calculated |
| Vitamine C | 1.0 milligramme | Not calculated |
| Vitamine D | 1000.0 UI | Not calculated |
| Vitamine D | 25.0 microgrammes | Not calculated |
| Magnésium | 246.0 milligramme | Not calculated |
| Magnésium | 4.0 milligramme | Not calculated |
| Zinc | 20.0 milligramme | Not calculated |
| Sélénium | 200.0 microgrammes | Not calculated |
| Cuivre | 2.0 milligramme | Not calculated |
| Manganèse | 9.0 milligramme | Not calculated |
| Chrome | 200.0 microgrammes | Not calculated |
| Molybdène | 100.0 microgrammes | Not calculated |
| Myo-inositol | 100.0 milligramme | Not calculated |
| (bêta-hydroxyéthyl)triméthylammonium | 100.0 milligramme | Not calculated |
| Acide-4-aminobenzoïque | 50.0 milligramme | Not calculated |
| Bore | 3.0 milligramme | Not calculated |
| Vanadium | 50.0 microgrammes | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 400 milligramme Potency : 50.0 % Polyphenols | 100.0 milligramme | Not calculated |
| Calcium | 496.0 milligramme | Not calculated |
| Calcium | 4.0 milligramme | Not calculated |
| Iode | 200.0 microgrammes | Not calculated |
| Acide d-pantothénique | 200.0 milligramme | Not calculated |
Non-medicinal ingredients
Poudre de feuilles de chou frisé, Poudre de Brassica oleracea italica (Brocoli), Extrait de fruit d'açaï, Saveur de baies, Poudre de Daucus carota, Epinard, Fibre de Betterave, Feuille de Stevia rebaudiana, Feuille de persil, Poudre de bleuet, Acide citrique, Extrait de framboise, Acide malique, Maltodextrine, Extrait de Punica Granatum, Betterave rouge
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Mesures | 1.0 Jour(s) |
Uses authorised in Canada
Source of vitamin A for the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps in tissue formation. Helps in connective tissue formation. Helps in wound healing. Source of antioxidants for the maintenance of good health. Helps to maintain proper muscle function. Provides support for healthy glucose metabolism. Helps to support liver function. Helps maintain healthy calcium metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Rare, unpredictable cases of liver injury associated with green tea extract-containing products have been reported (in Canada and internationally).
- Contre-indications
Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are a tobacco smoker. Consult a health care practitioner prior to use if you have a liver disorder. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have a history of non-melanoma skin cancer. Consult a health care practitioner prior to use if you have a kidney disorder and/or diabetes. Consult a healthcare practitioner prior to use if you are taking sulfonamides. If you have been diagnosed with estrogen-dependant cancer, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have an iron deficiency. If symptoms worsen, consult a health care practitioner. If you have a liver disorder, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner.
Source
Official Health Canada record, licence 80058440
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.